Evidence map›Paper›PMID 31217552›Full record

ArticleScientific reports2019

Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model.

Sriram Seshadri, Naimisha Rapaka, Bhumika Prajapati, Dipeeka Mandaliya, Sweta Patel, Christopher Shamir Muggalla, Bandish Kapadia, Phanithi Prakash Babu, Parimal Misra, Uday Saxena

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Effect ofInternational journal of molecular sciences · 2024
    Pooled it
  2. Article
  3. Synergistic effects ofHeliyon · 2024
    Article
  4. Review
  5. Article
  6. Statins Aggravate the Risk of Insulin Resistance in Human Muscle.International journal of molecular sciences · 2022
    Article
  7. Observational
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sriram SeshadriInstitute of Science, Nirma University, Ahmedabad, India.
Naimisha RapakaDr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad, 500 046, India.
Bhumika PrajapatiInstitute of Science, Nirma University, Ahmedabad, India.
Dipeeka MandaliyaInstitute of Science, Nirma University, Ahmedabad, India.
Sweta PatelInstitute of Science, Nirma University, Ahmedabad, India.
Christopher Shamir MuggallaDr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad, 500 046, India.
Bandish KapadiaDr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad, 500 046, India.ORCID http://orcid.org/0000-0001-6021-0008
Phanithi Prakash BabuDepartment of Biotechnology & Bioinformatics, School of Life Sciences, University of Hyderabad, Gachibowli, Hyderabad, 500 046, India.
Parimal MisraDr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad, 500 046, India. parimalm@drils.org.
Uday SaxenaDr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad, 500 046, India. usaxena@drils.org.
University of Hyderabad · INNirma University · INUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Statins are first-line therapy drugs for cholesterol lowering. While they are highly effective at lowering cholesterol, they have propensity to induce hyperglycemia in patients. Only limited studies have been reported which studied the impact of statins on (a) whether they can worsen glucose tolerance in a high sucrose fed animal model and (b) if so, what could be the molecular mechanism. We designed studies using high sucrose fed animals to explore the above questions. The high sucrose fed animals were treated with atorvastatin and simvastatin, the two most prescribed statins. We examined the effects of statins on hyperglycemia, glucose tolerance, fatty acid accumulation and insulin signaling. We found that chronic treatment with atorvastatin made the animals hyperglycemic and glucose intolerant in comparison with diet alone. Treatment with both statins lead to fatty acid accumulation and inhibition of insulin signaling in the muscle tissue at multiple points in the pathway.

Indexed as

Feeding BehaviorAnimalsAtorvastatinDietDisease Models, AnimalFatty AcidsGene Expression RegulationGlucose IntoleranceHydroxymethylglutaryl-CoA Reductase InhibitorsHyperglycemiaInsulinMusclesRatsSignal TransductionSimvastatinSucroseAtorvastatinFatty AcidsHydroxymethylglutaryl-CoA Reductase InhibitorsInsulinSimvastatinSucrose

Identifiers

PMID31217552
PMCPMC6584635
OpenAlexW2950260552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.